µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º z%E(o%l8
+.~K=.O)
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ ^mLX}E]
:#g.%&
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) ,marNG
l :{q I#Q
1. ICAM-1 T'}kCnp
q;[HUyY,
2. interleukin 12(IL-12) \d;)U4__!
=Fc]mcJ69
3. tumor infiltrating lymphocyte F'|K>!H
GZi`
jp
4. TCR/CD3 complex 1 ?BLL;[a8
[s$x"Ex
5. hematopoietin receptor family VLV]e_D6s
?;o0~][!
6. individual idiotype(IdI) Vz0
(D
~IYR&GEaUG
7. integrin X'b3
CS4
j_5&w Znq
8. colony-stimulatory factor (CSF) AM=> P7
E
G+/2o+W
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© qeFaY74S
hdWV vN
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? c3GBY@m
9n i
s8
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ 7 q!==P=
pq
r_{
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠEC5= 2w<
uDND o
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ 5 eL
b/,R
sCw>J#@2>
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) 6O,k! y>
va_u4
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ i7-i!`<
tl /i
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) k62s|VeU
EpO2%|@
3. immunoglobulin superfamily (IgSF) "f
89
d+G%\qpzQ
4. selectin &k,DAx`rN;
iJE:>qOTD5
5. anti-idiotypic antibody (¦ÁId) .'A1Eoo0d
]B;`Jf
6. major histocompatibility complex(MHC) q
8sfG ;)
fZ &
7. immunotolerance ,v mn{gz
3QBzyJWf
8. biological reponse modifier(BRM) FS=yc.Q_
OnE%D|Tq=
9. immune reponse gene (Ir gene) MG=8`J-`
Q<u?BA/
10. reshaped antibody (or reconstituted antibody) [u!n=ev
UL}wGWaoG
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 6d/Q"As
*GoTN
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ '4{=x]K
<-?C\c~G@
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? 3s?u05_
W;=Ae~
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ Ur]$@N
4j=K3m
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? }NyQ<,+mq&
{aUTTEu
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ ^D
+^~>f
=MQ/z#:-P
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? T
4wk$R
L
2rT^OGw6
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ \AroSy9
t?G6|3
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ Gu~*ZKyJ
-MS#YcsV
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? =W3
K
6w
iiQn/%
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ exhU!p8
X8ap
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: j~{cT/5Y_
a)ry}E =f
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ;9OhK71}
[-
$
Do
̉񧄤 K{ar)_V/
&$/
#"lW,V
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© RX>P-vp
@5nFa~*K%
1. CD8 *
HKu%g
JnsJ]_<
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) FoK2h!_
Ldj
z-
3. immunoglobulin fold(Ig fold) 0h@FHw2d
W91yj:
4. cadherin (Ca-dependent cell adhesion moleculers) rz "$zc.)
f,HUr% @
5. idiotype-anti-idiotypic antibody immune network theory K29/7A/
)]1hN;Nz
6. HLA class II antigen f4f2xe7\Q
5Kg'&B (
7. complementarity-determining region (CDR)
T^}UE<
@z@%vr=vX
8. perforin(or pore-forming protein ,PFP) v=N?(6T
F[jE#M=k
9. high affinity IL-2 receptor T`EV
uRJ
Rg?6e N
10. artificial active immunization sAkr-x?+M
,S-h~x
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© L80(9Y^xn
L^+rsxR
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ&~,4$&_
s*izhjjX
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 T D_@0Rd
;m(iKwDt
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ >d/H4;8
S0,\{j
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ @5%&wC
}|P3(*S
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ _Iy\,<
~e{ @ 5.g
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? ,;)ZF
%**f`L%jN
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ]b4WfIu
^ Bx[%
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ 6}4})B2
N^Re
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ Z>rY9VvWD
g52a
vG
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ PVCoXOqh
.G0 N+)
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© u!_l
/'\
COrk (
V
1. immunoglobulin gene rearrangement >yBqi^aL
yYG<tUG;
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) U ZM #O
K+B978XD
3. flow cytometry(FCM) 9njwAKF?
J!I)G&:
4. carrier effect gAqK)@8-
a)qan
5. positive selection of T lymphocytes in thymus W'lqNOX[v
yK~=6^M
6. mouse TH1(Th1) and TH2(Th2) subsets IPiV_c-l
{28|LwmL
7. perforin (pore-forming protein ,PFP) Fnw:alWr
qNp1<QO0
8. ADCC(antibody-dependent cell-mediated cytotoxicity) dUI5,3*
I=Y>z^4
9. SH-2(src-homology region 2) xO~ElzGm
:+rGBkw1m
10. Ab2¦Â (internal image) B/?
L$m
@f!X%)\;x
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© EY
}:aur
7R+(3NU1A
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? G#M)5'Q]U
!40>LpL[
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? nB[-KS
2G8pDvBr
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ1J@Iekat
2ZH+fV?.
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£
{pzj@b 1S
cs9^&N:w[
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠIgT`on3Y
d|`Ll
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) *6uccx7{
ITu19WG
ÃâÒßѧרҵ£º [3%
mNNk
s?SspuV
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ /@os*c|je
J
3!~e+wn
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? R[WiW RfD
S63Zk0(25
´«È¾²¡Ñ§×¨Òµ£º ?b7\m":'
8fR(y~_gF
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ @KG0QHyiU
y(A' *G9
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ c:[k+_Zr
Z$oy;j99y
Ïû»¯×¨Òµ£º E?m~DYnU
\&
JZ
>h
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ ?Ua,ba*
<@<rU:o=V
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? _z5/&tm_H
`-NK:;^
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ MNT~[Z9L5G
Cu
"Cpt[
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© %>_[b,
|dRVSVN
1. Fas(CD95)/FasL Obdn#Wm=
k.T=&0J_1
2. common chain of cytokine receptor Z%T Ajm
|diI(2w
3 . TCR/CD3 complex Vn
s3859$8
Aoa8Q
E
4. negaive selection of thymocytes ZsGvv]P
_0/unJl`
5. artificial active immune K+g[E<x\=
6Z\ aJ
6. anti-idiotypic Z:4/lx7Bq
tm1=
7. IgSF Mk!Fy]3
l.YE@EL
8. Integrin F!z0N
1 $E(8"l
9. chemokine 3i^X9[.
]>3Y~KH(
10. B7/CD28 3o.x<G(
I8H3*DE
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© W"{Ggk`
hCxg6e<[
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ y:G%p3h)[
E0HqXd?
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ Q3@ zUjq_Q
zAgX{$/Fg
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ xd Z$|{,
mxNd
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ LI,wSTVjC
1M ?BSH{
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ z?/_b
3(YvqPp&
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ IZVP-
{3Inj8a=?A
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© ZmK=8iN9J
)~2\4t4|g
1. B7/CD28 >oh Cz@~
N8A)lYT]_u
2. Th1 subset s$Vl">9#
zs$r>rlO
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© 9A|A@E#
7x)Pt@c
4. antibody affinity maturation *85N_+Wv!
O9ex=m `L
5. AP-1 m*^)#
<4r8H-(%
6. single chain variable fragment£¨ScFv£© !GOaBs
2z>-H595az
7. NK cell receptor b{0a/&&1O
G`!x+FB
8. Zinkernagel-Doherty phenomenon *g5bdQ:Av~
N{J
1C6
9. Ig fold !Asncc G
_CD~5EA:
10. CD40/CD40L 2A_1 E\
r]9-~1T
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© s|C[{n<_
\'|n.1Fr
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ e=;A3S
i6Z7O)V
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ w/@ZPBRo]
}s,NM%oI
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ f:PlMv!{
T
Q41i/{
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ } c
G)$E
ns~]a:1yh
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ a1pp=3Pd?~
@=kgK[t
9
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ )kep:-wm
v_KO xV:<`
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ =$OGHc
,Zmjw@w
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© ;nS
F\X(;{
x-i1:W9;
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© *}2L4]
oq7G=8gTp
1.Co-stimulators (or co-stimulating molecules) >/ay'EyY;>
m
>
=DJ{KQ
2.NK-kB ///Lg{ie
7y$\|WG?!r
3.Immunoglobulin superfamily
^kfqw0!
Kk^*#vR
4.antigen-presenting cell (APC) "t^v;?4
WEwa<%Ss
5.death domain PC9,;T&7_
SnE^\I^
O
6.CCR and CXCR xhP~]akHN7
vAX ( 3
7.Lectin (or mitogen) ;<Q%d~$xy}
k6C XuU
8.Clusters of differentiation, CD) H,} &=SCk
%,bD|
NKp
9.B7 family l~E~! MR
e|Ri
10.Cytotoxic T lymphocyte, CTL) 2 GRI<M
>NUbk9}J4
11.IL-15 and IL-15 receptor (IL-15R) krfXvQJwJ
;TL.QN/l
12.MHC restriction 8e?/LA%MU
%jHm9{|X
13.Affinity-chromatography
7IxeSxXH
JY
14.Cyctosprin A, CsA 7I;kh`H$(f
'?C6P5fm
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) iTHwH{!
G[KjK$.Ts?
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© -+ByK#<%
vh\i ^
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 nkHl;;WJ
L"ho|v9:
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ z_>
~=Mm
n%3!)/$
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ C&z!="hMhR
g@#he95 }
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© 8~(xi<"e
%"`p&aE:
ÃâÒßѧרҵ£º 1h@qcom9K_
+JEr
c)%
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ 5&8E{YXr
Y|R=^
=d\
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ `Moo WG
eDpi0htm
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ GDLi?3q
Nk9=
A4=|
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) D=ej%]@iw
4.,EKw3
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) Zbnxs.i!
d&^b=d FDu
1. ADCC(antibody dependent cell-mediated cytotoxicity) eV"%(<{
xVP
SL#>
2. »·æß¾úËØ(cyclosporin) jzf~n~
|*?N#0s5h
3. KIR(killer cell inhibitory receptor) [bnu
DS
s:_hsmc"
4. HLDA(human leucocyte differentiation antigen) mW{;$@PLF"
w"0$cL3
5. Interleukin 18(IL-18) eP2Q2C8g
k*A(7qQA`4
6. ÕûºÏËØ(integrin) <pk*z9
g/C 7wc
7. Fas/FasL _-f LD
3.YH7rN
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) OD'~t,St
O
?T~>|
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) d_
=K (}eR
SLuQv?R}9
10. Th1/Th2 Qb@j8Xa4[
7ZI{A*^vB
11. »ùÒòÒßÃç(DNAÒßÃç) ai?uJ}
P{dR
pH|
12. chemokines and chemokine receptor U>t:*SNC*
VQ!4(
<XD
13. ÃâÒßÄÍÊÜ |!K&h(J|
Y<;C>Rs
14. ¹²´Ì¼¤·Ö×Ó L\ysy2E0
c+{XP&g8_J
15. ËÀÍö½á¹¹Óò(death domain) DQhHU1
m:Rx<E
E
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) Yy
4Was#
^Whc<>|
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? NH/jkt&F[
4`~OxL
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠ2h5T$[fV
e~QLzZ3
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î [
2@Lc3<
W9cvxsox
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ ,=!s;+lu{
a:|]F|
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå Q3lVx5G>4
~i^,Z&X:
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ IAd^$9
WV}pE~
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) l$BKE{rg
/X
R
gsF
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ i_6 wD
(`n*d3
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ @TKQ_7BcB
?fs#K;w
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£